BioXmark® builds on a solid scientific platform, and we are continuously engaging with healthcare professionals and other research partners to establish new knowledge and broaden the clinical and scientific evidence behind our product.
Under the links below, we have grouped references to published studies of BioXmark, whether clinical or non-clinical, and to technology and innovation-driven studies, all supporting the relevance and performance of this liquid fiducial marker to guide high-precision radiotherapy of several cancer types and investigating also its applicability in other use areas.
BioXmark® – Clinical studies
BioXmark® – Non-clinical studies
Nanovi – Technology and innovation
See or download a complete list of BioXmark® study publications: BioXmark publication list